Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Hofherr

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|August 5, 2025
A Case Study of Model-Informed Drug Development of a Novel PCSK9 Antisense Oligonucleotide. Part 2: Phase 2 to Phase 3Jane Knöchel, Catarina Nilsson, Björn Carlsson, et al.
Biology|May 28, 2022
Single Gene Mutations in <i>Pkd1</i> or <i>Tsc2</i> Alter Extracellular Vesicle Production and TraffickingPrashant Kumar, Fahad Zadjali, Ying Yao, et al.
Autophagy|September 24, 2020
Loss of PKD1/polycystin-1 impairs lysosomal activity in a CAPN (calpain)-dependent mannerLukas Peintner, Anusha Venkatraman, Astrid Waeldin, et al.
Pflugers Archiv : European Journal of Physiology|December 18, 2016
Efficient genome editing of differentiated renal epithelial cellsAlexis Hofherr, Tilman Busch, Nora Huber, et al.
British Journal of Clinical Pharmacology|March 20, 2024
Population pharmacokinetics of a novel PCSK9 antisense oligonucleotideOskar Clewe, Dinko Rekić, Angelica L Quartino, et al.
Scientific Reports|August 17, 2021
Rapid target validation in a Cas9-inducible hiPSC derived kidney modelYasaman Shamshirgaran, Anna Jonebring, Anna Svensson, et al.
Scientific Reports|July 24, 2021
Identification of pathological transcription in autosomal dominant polycystic kidney disease epitheliaSebastian Friedrich, Hannah Müller, Caroline Riesterer, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 20, 2022
A case-study of model-informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase IIJane Knöchel, Catarina Nilsson, Björn Carlsson, et al.
Nature Cell Biology|December 18, 2019
Author Correction: Eomes and Brachyury control pluripotency exit and germ-layer segregation by changing the chromatin stateJelena Tosic, Gwang-Jin Kim, Mihael Pavlovic, et al.
Advances in Therapy|January 27, 2024
Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI)Haiting Wu, Hong Cheng, Caili Wang, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
CPT: Pharmacometrics & Systems Pharmacology|August 5, 2025
A Case Study of Model-Informed Drug Development of a Novel PCSK9 Antisense Oligonucleotide. Part 2: Phase 2 to Phase 3Jane Knöchel, Catarina Nilsson, Björn Carlsson, et al.
Biology|May 28, 2022
Single Gene Mutations in <i>Pkd1</i> or <i>Tsc2</i> Alter Extracellular Vesicle Production and TraffickingPrashant Kumar, Fahad Zadjali, Ying Yao, et al.
Autophagy|September 24, 2020
Loss of PKD1/polycystin-1 impairs lysosomal activity in a CAPN (calpain)-dependent mannerLukas Peintner, Anusha Venkatraman, Astrid Waeldin, et al.
Pflugers Archiv : European Journal of Physiology|December 18, 2016
Efficient genome editing of differentiated renal epithelial cellsAlexis Hofherr, Tilman Busch, Nora Huber, et al.
British Journal of Clinical Pharmacology|March 20, 2024
Population pharmacokinetics of a novel PCSK9 antisense oligonucleotideOskar Clewe, Dinko Rekić, Angelica L Quartino, et al.
Scientific Reports|August 17, 2021
Rapid target validation in a Cas9-inducible hiPSC derived kidney modelYasaman Shamshirgaran, Anna Jonebring, Anna Svensson, et al.
Scientific Reports|July 24, 2021
Identification of pathological transcription in autosomal dominant polycystic kidney disease epitheliaSebastian Friedrich, Hannah Müller, Caroline Riesterer, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 20, 2022
A case-study of model-informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase IIJane Knöchel, Catarina Nilsson, Björn Carlsson, et al.
Nature Cell Biology|December 18, 2019
Author Correction: Eomes and Brachyury control pluripotency exit and germ-layer segregation by changing the chromatin stateJelena Tosic, Gwang-Jin Kim, Mihael Pavlovic, et al.
Advances in Therapy|January 27, 2024
Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI)Haiting Wu, Hong Cheng, Caili Wang, et al.
Pageof 3